Maxygen (MAXY) Cash Flow Statement

Click line-items for a historical chart and %

Operating activities
Loss from continuing operations
Depreciation and amortization	26K
Gain on distribution of equity securities	-60K
Non-cash stock compensation	1.37M
Valuation of stock purchase warrants
Deferred income tax benefit
Valuation of stock portion of distribution payable	4K
Related party receivable
Grant and other receivables
Receivable from Perseid
Prepaid expenses and other current assets	53K
Deposits and other non-current assets	0
Accounts payable	136K
Accrued compensation	1.01M
Accrued restructuring charges
Other accrued liabilities	-208K
Deferred revenue
Net cash used in operating activities	-2.76M
Investing activities
Purchases of available-for-sale securities	-5M
Maturities of available-for-sale securities
Proceeds from sale of discontinued operations
Net cash provided by investing activities	15M
Cash distributions paid to common stockholders	-622K
Sale of subsidiary shares to non-controlling interest
Proceeds from issuance of common stock, net of stock repurchased to settle employee tax obligations	-23K
Repurchase of common stock	0
Net cash used in financing activities	-645K
Operating activities
Investing activities
Net cash used in discontinued operations
Net increase in cash and cash equivalents	11.6M
Cash and cash equivalents at beginning of period	62.78M
Cash and cash equivalents at end of period	74.38M

Entities mentioned with MAXY

View All Entities